Article Text
Editorial
The search for the tipping point on when to anticoagulate patients with atrial fibrillation
Statistics from Altmetric.com
Footnotes
Competing interests The author reports receiving consulting fees as member of the scientific advisory boards for Boehringer-Ingelheim, Bayer, Bristol-Myers Squibb-Pfizer, Daiichi-Sankyo and Cardiome and reports receiving lecture fees from these same companies.
Provenance and peer review Commissioned; internally peer reviewed.